CO6430435A2 - Nuevas vacunas combinadas con células completas de pertussis y método de fabricación de las mismas - Google Patents
Nuevas vacunas combinadas con células completas de pertussis y método de fabricación de las mismasInfo
- Publication number
- CO6430435A2 CO6430435A2 CO11063984A CO11063984A CO6430435A2 CO 6430435 A2 CO6430435 A2 CO 6430435A2 CO 11063984 A CO11063984 A CO 11063984A CO 11063984 A CO11063984 A CO 11063984A CO 6430435 A2 CO6430435 A2 CO 6430435A2
- Authority
- CO
- Colombia
- Prior art keywords
- vaccine
- manufacturing
- antigens
- pertussis
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se relaciona con una vacuna combinada que comprende una mezcla de antígenos para protección contra enfermedades tales como difteria, tétanos, tos ferina (coqueluche) con células completas y polio. La presente invención también ser relaciona con la inclusión de uno o más antígenos en dicha vacuna combinada, para protección contra infecciones causadas por Haemophilus influenzae, virus de la hepatitis, y otros patógenos, tal que la administración de la vacuna puede inmunizar simultáneamente al sujeto contra más de un patógeno. La invención en particular se relaciona con una vacuna combinada completamente líquida y estable que comprende los antígenos indicados más arriba y con los métodos para fabricar dicha vacuna.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2437DE2008 | 2008-10-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6430435A2 true CO6430435A2 (es) | 2012-04-30 |
Family
ID=42119002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11063984A CO6430435A2 (es) | 2008-10-24 | 2011-05-24 | Nuevas vacunas combinadas con células completas de pertussis y método de fabricación de las mismas |
Country Status (14)
Country | Link |
---|---|
US (1) | US20110195087A1 (es) |
EP (2) | EP2529750A1 (es) |
JP (1) | JP2012506420A (es) |
CN (1) | CN102196817B (es) |
AP (1) | AP2011005700A0 (es) |
AR (1) | AR073957A1 (es) |
BR (1) | BRPI0920629A2 (es) |
CA (1) | CA2741393A1 (es) |
CL (1) | CL2011000913A1 (es) |
CO (1) | CO6430435A2 (es) |
MA (1) | MA32821B1 (es) |
PE (1) | PE20100365A1 (es) |
RU (2) | RU2504398C2 (es) |
WO (1) | WO2010046934A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102633898B (zh) * | 2012-04-23 | 2013-11-27 | 成都欧林生物科技股份有限公司 | 一种Hib多糖与蛋白结合工艺的优化方法 |
US9849066B2 (en) | 2013-04-24 | 2017-12-26 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
CN106075428A (zh) * | 2015-07-01 | 2016-11-09 | 北京科兴中维生物技术有限公司 | 一种免疫原性组合物及其制备方法 |
MA42317B2 (fr) * | 2015-09-16 | 2021-11-30 | Lg Chemical Ltd | Composition de vaccin combinée pour administration multiple |
WO2018037365A1 (en) * | 2016-08-26 | 2018-03-01 | Serum Institute Of India Private Limited | Multivalent vaccine composition |
SG11202000224SA (en) * | 2017-07-18 | 2020-02-27 | Serum Inst Of India Pvt Ltd | An immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogenicity and process for preparation thereof |
JOP20190242A1 (ar) * | 2018-10-12 | 2020-04-12 | Serum Institute Of India Pvt Ltd | تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها |
WO2020165920A1 (en) * | 2019-02-12 | 2020-08-20 | Biological E Limited | Multivalent vaccine composition |
WO2021176409A1 (en) | 2020-03-05 | 2021-09-10 | Sanofi Healthcare India Private Limited | Preservative combination for vaccine composition |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3097140A (en) | 1958-10-31 | 1963-07-09 | Merck & Co Inc | Preparing a mixed polio, pertussis, tetanus, and diphtheria vaccine with benzethonium chloride |
US3097142A (en) | 1960-03-30 | 1963-07-09 | Merck & Co Inc | Benzyl alcohol stabilized polio vaccines and production thereof |
ES2118963T3 (es) * | 1992-05-23 | 1998-10-01 | Smithkline Beecham Biolog | Vacunas combinadas, que contienen antigeno de superficie de la hepatitis b y otros antigenos. |
US6488934B1 (en) * | 1995-02-25 | 2002-12-03 | Smithkline Beecham Biologicals S.A. | Hepatitis B vaccine |
FR2734484B1 (fr) * | 1995-05-24 | 1997-06-27 | Pasteur Merieux Serums Vacc | Composition vaccinale liquide et procede de fabrication |
JP3280675B2 (ja) | 1996-07-02 | 2002-05-13 | コノート ラボラトリーズ リミテッド | 多価dtpポリオワクチン |
CA2783274C (en) | 2000-06-29 | 2018-08-07 | Glaxosmithkline Biologicals S.A. | Multivalent vaccine composition with reduced dose of haemophilus influenza type b |
KR100385711B1 (ko) | 2000-07-05 | 2003-05-27 | 녹십자백신 주식회사 | 디프테리아, 파상풍 톡소이드와 백일해균 및b형간염표면항원을 포함한 4가 혼합백신 및 그 제조방법 |
GB0223355D0 (en) | 2002-10-08 | 2002-11-13 | Chiron Spa | Vaccine |
GB0313916D0 (en) | 2003-06-16 | 2003-07-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
KR20030069918A (ko) | 2003-06-25 | 2003-08-27 | 주식회사 삼정산업 | 간편 조립식 파렛트 판재, 간편 조립식 파렛트 중간지지구및 간편 조립식 파렛트와 그의 제작방법 |
GB0405787D0 (en) | 2004-03-15 | 2004-04-21 | Chiron Srl | Low dose vaccines |
EA010057B1 (ru) * | 2004-08-27 | 2008-06-30 | Панацея Биотек Лтд. | Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита |
PL2097102T3 (pl) | 2006-09-07 | 2012-10-31 | Glaxosmithkline Biologicals Sa | Szczepionka skojarzona o zmniejszonej ilości antygenu wirusa polio |
-
2009
- 2009-10-22 PE PE2009001195A patent/PE20100365A1/es not_active Application Discontinuation
- 2009-10-23 CN CN200980142458.8A patent/CN102196817B/zh active Active
- 2009-10-23 US US13/125,679 patent/US20110195087A1/en not_active Abandoned
- 2009-10-23 AR ARP090104078A patent/AR073957A1/es unknown
- 2009-10-23 AP AP2011005700A patent/AP2011005700A0/xx unknown
- 2009-10-23 RU RU2011120309/15A patent/RU2504398C2/ru active
- 2009-10-23 EP EP11173119.6A patent/EP2529750A1/en not_active Withdrawn
- 2009-10-23 JP JP2011532773A patent/JP2012506420A/ja not_active Withdrawn
- 2009-10-23 WO PCT/IN2009/000599 patent/WO2010046934A1/en active Application Filing
- 2009-10-23 EP EP09821705A patent/EP2361094A4/en not_active Withdrawn
- 2009-10-23 CA CA2741393A patent/CA2741393A1/en not_active Abandoned
- 2009-10-23 BR BRPI0920629A patent/BRPI0920629A2/pt not_active Application Discontinuation
-
2011
- 2011-04-21 CL CL2011000913A patent/CL2011000913A1/es unknown
- 2011-05-20 MA MA33877A patent/MA32821B1/fr unknown
- 2011-05-24 CO CO11063984A patent/CO6430435A2/es not_active Application Discontinuation
- 2011-08-29 RU RU2011135761A patent/RU2613295C2/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2613295C2 (ru) | 2017-03-15 |
AP2011005700A0 (en) | 2011-06-30 |
WO2010046934A1 (en) | 2010-04-29 |
CN102196817B (zh) | 2016-04-06 |
RU2011135761A (ru) | 2013-03-10 |
CL2011000913A1 (es) | 2012-01-20 |
BRPI0920629A2 (pt) | 2016-01-12 |
CA2741393A1 (en) | 2010-04-29 |
PE20100365A1 (es) | 2010-05-21 |
AR073957A1 (es) | 2010-12-15 |
EP2361094A1 (en) | 2011-08-31 |
EP2529750A1 (en) | 2012-12-05 |
CN102196817A (zh) | 2011-09-21 |
RU2011120309A (ru) | 2012-11-27 |
RU2504398C2 (ru) | 2014-01-20 |
EP2361094A4 (en) | 2012-12-05 |
MA32821B1 (fr) | 2011-11-01 |
JP2012506420A (ja) | 2012-03-15 |
US20110195087A1 (en) | 2011-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6430434A2 (es) | Nuevas composiciones de vacunas con pertussis acelular y método de fabricación de las mismas | |
CO6430435A2 (es) | Nuevas vacunas combinadas con células completas de pertussis y método de fabricación de las mismas | |
WO2012093406A3 (en) | A combination heptavalent vaccine | |
PH12019500289A1 (en) | Vaccines directed against a human enteroviruses | |
MX2020011717A (es) | Composiciones de vacuna que tienen estabilidad e inmunogenicidad mejoradas. | |
BR112012004698A2 (pt) | métodos de redução de atividade virucida em composições de pcv-2 e composições de pcv-2 com uma imonugenicidade aprimorada. | |
MX2021006342A (es) | Mutantes de virus de influenza y usos para los mismos. | |
ECSP14005678A (es) | Composiciones y métodos para tratar el virus de la hepatitis c | |
AR092896A1 (es) | Composiciones inmunogenicas | |
WO2010019262A3 (en) | Polyvalent vaccine | |
GT201500046A (es) | Mètodos para el tratamiento de infecciones de hepatitis b y hepatitis d | |
BR112012033767A2 (pt) | processo para produzir um vírus de interesse, para remover um agente adventício, e para remover um agente adventício, vírus,e, composição imunogênica ou vacina. | |
NZ603863A (en) | Concentration and lyophilization of influenza vaccine antigens | |
AR080111A1 (es) | Metodos y composiciones de inmunizacion | |
NZ715459A (en) | A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same | |
NZ630831A (en) | Compositions and methods for administration of vaccines against dengue virus | |
EA201500701A1 (ru) | Способ создания вакцины против микоплазм | |
NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
AR088580A1 (es) | Metodos y composiciones para tratar el virus de la hepatitis c | |
CU20190013A7 (es) | Composiciones de vacunas multivalentes | |
MX2016001695A (es) | Composiciones inmunogenas de combinacion. | |
WO2012118559A3 (en) | Tetravalent and mixed head bivalent dengue vaccine | |
AR117191A1 (es) | Composiciones inmunogénicas | |
AR089737A1 (es) | Procedimiento de formulacion de una vacuna que contiene al menos dos antigenos susceptibles de adsorberse sobre el oxi-hidroxido de aluminio | |
ECSP21087299A (es) | Composiciones y métodos para tratar el virus de la hepatitis c |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |